share_log

Truist Securities Maintains Buy on Affimed, Lowers Price Target to $6

Truist Securities Maintains Buy on Affimed, Lowers Price Target to $6

Truist Securities維持對Affimed的買入,將目標股價下調至6美元
Benzinga ·  2023/08/11 10:09

Truist Securities analyst Srikripa Devarakonda maintains Affimed (NASDAQ:AFMD) with a Buy and lowers the price target from $8 to $6.

Truist證券分析師Srikripa Devarakonda維持Affimed(納斯達克:AFMD)的買入,並將目標價從8美元下調至6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論